These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 31599402
1. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2. Cheng F, Yang MM, Yang RH. Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7766-7774. PubMed ID: 31599402 [Abstract] [Full Text] [Related]
2. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs. Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y, Liao Y. Biochem Biophys Res Commun; 2019 Aug 27; 516(3):666-672. PubMed ID: 31248594 [Abstract] [Full Text] [Related]
3. MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1. Luo B, Yang JF, Wang YH, Qu GB, Hao PD, Zeng ZJ, Yuan J, Yang R, Yuan Y. Eur Rev Med Pharmacol Sci; 2019 Aug 27; 23(16):6791-6799. PubMed ID: 31486477 [Abstract] [Full Text] [Related]
4. Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression. Yang L, Zeng Z, Kang N, Yang JC, Wei X, Hai Y. Eur Rev Med Pharmacol Sci; 2019 Feb 27; 23(3):949-957. PubMed ID: 30779060 [Abstract] [Full Text] [Related]
5. LncRNA XIXT promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression by targeting miRNA-30a-5p. Zhang HL, Du XY, Dong QR. Eur Rev Med Pharmacol Sci; 2019 Oct 27; 23(20):8721-8729. PubMed ID: 31696458 [Abstract] [Full Text] [Related]
11. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells. Lv R, Pan X, Song L, Sun Q, Guo C, Zou S, Zhou Q. Biomed Pharmacother; 2019 Aug 27; 116():108960. PubMed ID: 31112871 [Abstract] [Full Text] [Related]
12. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression. Zhou JG, Hua Y, Liu SW, Hu WQ, Qian R, Xiong L. Eur Rev Med Pharmacol Sci; 2020 Jan 27; 24(1):1-10. PubMed ID: 31957812 [Abstract] [Full Text] [Related]
13. A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells. Zhang X, Xu J. Bone; 2024 Aug 27; 185():117123. PubMed ID: 38735373 [Abstract] [Full Text] [Related]
18. Silencing of Long Non-Coding RNA NONHSAT009968 Ameliorates the Staphylococcal Protein A-Inhibited Osteogenic Differentiation in Human Bone Mesenchymal Stem Cells. Cui Y, Lu S, Tan H, Li J, Zhu M, Xu Y. Cell Physiol Biochem; 2016 Jun 21; 39(4):1347-59. PubMed ID: 27607236 [Abstract] [Full Text] [Related]
19. LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2. Feng J, Wang JX, Li CH. Eur Rev Med Pharmacol Sci; 2019 Sep 21; 23(18):7757-7765. PubMed ID: 31599401 [Abstract] [Full Text] [Related]
20. miR‑488 negatively regulates osteogenic differentiation of bone marrow mesenchymal stem cells induced by psoralen by targeting Runx2. Huang Y, Hou Q, Su H, Chen D, Luo Y, Jiang T. Mol Med Rep; 2019 Oct 21; 20(4):3746-3754. PubMed ID: 31485621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]